JSP
AMAG

Jackson Square Partners’s AMAG Pharmaceuticals AMAG Stock Holding History

Jackson Square Partners’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,983
Closed -$173K – 85
2019
Q3 		$173K Hold
14,983
– – ﹤0.01% 78
2019
Q2 		$149K Sell
14,983
-75,170
-83% -$811K ﹤0.01% 78
2019
Q1 		$1.16M Sell
90,153
-2,869,845
-97% -$42.7M 0.01% 78
2018
Q4 		$45M Buy
2,959,998
+127,397
+4% +$2.43M 0.28% 72
2018
Q3 		$56.7M Buy
2,832,601
+158,281
+6% +$3.6M 0.29% 68
2018
Q2 		$52.1M Buy
+2,674,320
New +$59.2M 0.27% 74

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jackson Square Partners's AMAG Position: Q4 2019 in Review

Jackson Square Partners sold out of AMAG Pharmaceuticals (AMAG) in Q4 2019, closing a stake of 14,983 shares — an estimated $173K sold.

Jackson Square Partners first reported a position in AMAG in Q2 2018 and held it in 6 quarters. The position peaked at $56.7M in Q3 2018. 134 funds tracked by Wall St. Rank hold AMAG as of Q4 2019.

  • Jackson Square Partners reported no remaining AMAG Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Jackson Square Partners sold 14,983 AMAG Pharmaceuticals shares in Q4 2019, an estimated $173K.
  • Jackson Square Partners first reported a position in AMAG Pharmaceuticals in Q2 2018 and held it in 6 quarters.
  • Jackson Square Partners's AMAG Pharmaceuticals position peaked at $56.7M in Q3 2018.
  • 134 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2019.

Based on Jackson Square Partners's 13F filing for Q4 2019, filed 13 Feb 2020.